Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,550 | -61,342 | -40,193 | -19,426 | -59,925 |
| Depreciation Amortization | 60 | -81 | -159 | -44 | 562 |
| Accounts payable and accrued liabilities | 1,733 | -623 | 801 | 1,768 | 2,751 |
| Other Working Capital | 5,825 | 769 | 904 | -194 | 6,433 |
| Other Operating Activity | 5,684 | 5,987 | 2,467 | -437 | 1,356 |
| Operating Cash Flow | $-72,248 | $-55,290 | $-36,180 | $-18,333 | $-48,823 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -699 | -683 | -469 | -234 | -476 |
| Purchase Of Investment | -114,685 | -65,118 | -63,123 | -63,123 | N/A |
| Sale Of Investment | 65,775 | 55,675 | 20,600 | 0 | N/A |
| Investing Cash Flow | $-49,609 | $-10,126 | $-42,992 | $-63,357 | $-476 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,650 | 29,649 | 19,650 | 19,649 | 290 |
| Debt Repayment | N/A | N/A | N/A | N/A | -4,698 |
| Common Stock Issued | 312,072 | 277 | 98 | 21 | 56,110 |
| Other Financing Activity | -125 | -125 | -125 | -125 | 95,968 |
| Financing Cash Flow | $341,597 | $29,801 | $19,623 | $19,545 | $147,670 |
| Beginning Cash Position | 115,017 | 115,017 | 115,017 | 115,017 | 16,646 |
| End Cash Position | 334,757 | 79,402 | 55,468 | 52,872 | 115,017 |
| Net Cash Flow | $219,740 | $-35,615 | $-59,549 | $-62,145 | $98,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,248 | -55,290 | -36,180 | -18,333 | -48,823 |
| Capital Expenditure | -699 | -683 | -469 | -234 | -476 |
| Free Cash Flow | -72,947 | -55,973 | -36,649 | -18,567 | -49,299 |